The Nipah Virus

The Nipah Virus: A Serious Zoonotic Threat – What Pharmacists and the Public in Pakistan Need to Know

By Naeem Mustafa, Pharmacist

January 30, 2026

As a pharmacist practicing in 

Rahim Yar Khan, Punjab, I closely monitor emerging infectious diseases that could impact our communities, especially those with cross-border implications. The recent confirmation of Nipah virus (NiV) cases in West Bengal, India, has once again brought this deadly zoonotic pathogen into the spotlight. While the situation remains contained and the risk to Pakistan is assessed as low by health authorities, awareness is crucial for early recognition, prevention, and community education.

The Nipah Virus

What is Nipah Virus?

Nipah virus is a highly pathogenic virus belonging to the Henipavirus genus in the Paramyxoviridae family. It was first identified during a major outbreak among pig farmers in Malaysia and Singapore in 1998–1999. Fruit bats (Pteropus species, commonly known as flying foxes) serve as the natural reservoir, where the virus causes no apparent illness. Spillover events occur when humans come into contact with infected bats, contaminated food, or amplifying hosts like pigs.

In South Asia, particularly Bangladesh and parts of India, outbreaks have been recurrent since the early 2000s, often linked to consumption of raw date palm sap contaminated by bat saliva or urine.

Recent Developments in January 2026

In late January 2026, Indian authorities confirmed two laboratory-positive cases of Nipah virus in West Bengal state. Both patients are 25-year-old nurses (one male and one female) working at the same private hospital in Barasat, near Kolkata. Symptoms began in late December 2025, progressing to neurological complications (encephalitis). The cases were confirmed by RT-PCR testing at the National Institute of Virology in Pune.

These appear to involve human-to-human transmission in a healthcare setting through close contact. Over 196 contacts were traced, all tested negative and remained asymptomatic as of late January. One patient is improving, while the other remains critically ill. The World Health Organization (WHO) classifies the sub-national risk in West Bengal as moderate due to bat reservoirs in border areas with Bangladesh, but national and global risk as low. No evidence of wider community spread exists, and India has demonstrated strong containment capacity.

In response, several Asian countries—including Pakistan—have enhanced airport and border screenings, including thermal checks and travel history reviews for arrivals from affected regions. Pakistan's Border Health Services and National Institutes of Health (NIH) emphasize vigilance, but experts note the overall risk of an outbreak here remains minimal, given no prior human or animal cases and the virus's specific transmission dynamics.

How Nipah Virus Spreads

Nipah transmits through multiple routes:

Zoonotic spillover: Direct contact with infected bats, their urine/saliva on fruits, or raw date palm sap (common in outbreaks).

Intermediate hosts: Contact with infected pigs (as in Malaysia) or other animals.

Human-to-human: Close contact with an infected person's bodily fluids, especially respiratory droplets or saliva—most common in healthcare or household settings.

It is not highly airborne like some respiratory viruses but spreads efficiently in close-proximity scenarios. Incubation period: typically 4–14 days (up to 21 days or rarely longer).

Signs and Symptoms

Early symptoms mimic common illnesses:

Fever

Headache

Muscle pain

Sore throat

Cough

Difficulty breathing

Vomiting

In severe cases (often progressing rapidly):

Dizziness and drowsiness

Confusion

Seizures

Encephalitis (brain inflammation)

Coma

The case fatality rate ranges from 40–75%, higher in some outbreaks, depending on timely supportive care.

Diagnosis, Treatment, and Management

Diagnosis relies on RT-PCR from throat swabs, blood, urine, or cerebrospinal fluid, available at reference labs like NIH in Pakistan.

No specific antiviral or licensed vaccine exists yet (though candidates are in trials). Treatment is supportive:

Hospitalization and intensive care (respiratory support, hydration, seizure management).

Early intervention significantly improves outcomes.

Pharmacists play a key role in advising on symptom management, infection control, and referring suspected cases promptly.

Prevention Strategies – Key Advice for Pakistan

Given our proximity to India and Bangladesh, and travel links:

Avoid consuming raw date palm sap or unwashed fruits in high-risk seasons/areas.

Do not handle bats or sick animals; avoid bat-roosting sites.

In healthcare settings: Use standard precautions (PPE, hand hygiene) for patients with unexplained fever + neurological/respiratory symptoms.

Practice good hygiene: Wash fruits thoroughly, peel before eating.

Travelers from affected regions: Monitor for symptoms for 21 days; seek immediate care if fever develops.

Public education: Raise awareness without causing panic—focus on hygiene and avoiding risky foods.

Pakistan's health authorities have adequate diagnostic capacity and rapid response mechanisms. The current regional alerts are precautionary, and the virus does not spread easily like influenza or COVID-19.

Final Thoughts

Nipah virus serves as a reminder of the importance of One Health approaches—integrating human, animal, and environmental surveillance. As pharmacists, we are on the front lines of community health education and early detection. Stay informed through reliable sources like WHO, Pakistan's NIH, and provincial health departments.

If you experience flu-like symptoms with neurological signs after potential exposure, consult a healthcare provider immediately. Vigilance, not fear, is the best defense.

Stay safe and informed.

Naeem Mustafa

Pharmacist

PharmaServePK

(References: WHO updates January 2026, ECDC, Reuters, Pakistan NIH statements, and CDC/WHO fact sheets on Nipah virus.)

How to Manage Diabetes with Lifestyle Changes

Lifestyle modifications are a cornerstone of diabetes mellitus (DM) management for both type 1 and type 2 diabetes. 

They help improve blood glucose control, reduce complications (e.g., heart disease, kidney issues, nerve damage), support weight management (especially important in type 2), and may reduce medication needs. Type 2 DM benefits most from these changes, while type 1 requires careful coordination with insulin therapy. Always consult your healthcare provider or a registered dietitian before making major changes, as plans must be individualized.

How to Manage Diabetes with Lifestyle Changes

1. Healthy Eating / Nutrition Therapy

No single "diabetes diet" focus on an individualized, balanced eating plan developed with a professional.

Key approaches: Carbohydrate counting (track grams of carbs per meal, especially if using insulin) or the plate method (½ plate non-starchy vegetables, ¼ plate lean protein, ¼ plate whole grains/starchy vegetables).

Prioritize: Vegetables (especially non-starchy like leafy greens, broccoli), whole fruits (in moderation), whole grains (oats, quinoa, brown rice), lean proteins (fish, poultry, beans, lentils, tofu, eggs), fat-free/low-fat dairy or alternatives, healthy fats (avocados, nuts, seeds, olive oil).

Limit: Added sugars (sweets, sodas, juices), refined carbs (white bread, pastries), saturated fats (<10% of calories), sodium (<2,300 mg/day, ideally less), processed foods.

Evidence-based patterns (per ADA): Mediterranean-style (emphasizes vegetables, fruits, whole grains, fish, olive oil) and low-carbohydrate eating patterns show benefits for glycemic control and preventing/delaying type 2 DM.

Protein goal (ADA 2026): At least 0.8 g/kg body weight per day to maintain muscle mass, especially during weight loss.

Meal timing/habits: Eat consistent carb amounts at meals; some benefit from eating most carbs earlier in the day or using nutrient sequencing (e.g., vegetables/protein before carbs to blunt glucose spikes).

Portion control and calorie awareness are essential for weight management.

2. Physical Activity and Exercise

Aim for at least 150 minutes per week of moderate-intensity aerobic activity (e.g., brisk walking, cycling, swimming, dancing) spread over ≥3 days/week, with no more than 2 consecutive days without activity. Vigorous activity (e.g., running) can count as double time (75 min/week target).

Include resistance/strength training (e.g., weights, bodyweight exercises, resistance bands) 2–3 days/week.

ADA 2026 emphasizes increasing to ≥60 minutes/day of moderate-to-vigorous activity (especially relevant for youth or in obesity treatment contexts) and activities that build bone and muscle strength.

Benefits: Muscles use glucose for energy, improving insulin sensitivity and lowering blood sugar. Post-meal walks (10–15 minutes) can blunt glucose spikes.

Reduce sedentary time (break up prolonged sitting). Start slowly if inactive; pre-exercise medical clearance may be needed.

3. Weight Management

For overweight or obese individuals (common in type 2 DM): Aim for 5–7% body weight loss from baseline (e.g., 5–7 kg if 100 kg). This improves blood glucose, blood pressure, cholesterol, and reduces cardiovascular risk.

Combine reduced calorie intake, healthy eating patterns, increased physical activity, and behavioral support (counseling, apps, programs).

Even modest loss helps; sustained changes are key. ADA recommends yearly screening for overweight/obesity using BMI + waist measurements.

4. Other Key Lifestyle Changes

Smoking cessation: Smoking worsens insulin resistance, increases complications (heart disease, stroke, kidney/nerve damage), and raises blood sugar. Quitting is highly beneficial; seek support (counseling, medications, nicotine replacement).

Alcohol: Limit to ≤1 drink/day for women, ≤2 for men (1 drink = 12 oz beer, 5 oz wine, 1.5 oz spirits). Alcohol can cause hypoglycemia (especially with insulin or certain meds); drink with food and monitor glucose.

Stress management: 

Chronic stress raises blood sugar. Try deep breathing, meditation, yoga, walking, hobbies, or support groups.

Sleep: Aim for 7–9 hours/night of quality sleep; poor sleep affects glucose control and appetite.

Monitor blood glucose: 

Regularly check levels (frequency depends on treatment; CGM recommended in many cases per ADA), log meals/activity/meds, and adjust as needed.

Routine care: 

Regular check-ups, foot/eye/kidney screenings, vaccinations, medication adherence (lifestyle complements, does not replace, meds when prescribed)

Programs like the CDC/ADA-recognized Diabetes Prevention Program or National DPP lifestyle change programs can provide structured support (group sessions, coaching) and have been shown to cut type 2 DM risk by over 50% in high-risk people.

These changes work best when sustained long-term. Track progress (e.g., via CGM, logs, HbA1c), celebrate small wins, and involve family/support. In regions like Pakistan, affordable options include walking, home-cooked balanced meals with local vegetables/dal/roti (controlled portions), and community health resources. Work closely with your doctor for personalized targets, hypoglycemia prevention (key in type 1), and integration with any medications or technology. Early and consistent lifestyle changes yield major benefits.

Diabetes and Neuropathy

 

Diabetes and Neuropathy: A Silent but Serious Complication

Author: Naeem Mustafa, Pharmacist
Platform: PharmaservePK

---

Introduction

Diabetes mellitus is one of the fastest-growing global health challenges, affecting millions of people worldwide. While high blood sugar is the primary feature of diabetes, its long-term complications can be far more dangerous. One of the most common and disabling complications is diabetic neuropathy—a type of nerve damage caused by prolonged high glucose levels.

Diabetes and Neuropathy

Diabetic neuropathy often develops silently and may remain unnoticed until significant nerve damage has occurred. Early awareness, proper control, and timely treatment can prevent serious outcomes such as foot ulcers, infections, and even amputations.

---

What Is Diabetic Neuropathy?

Diabetic neuropathy is a nerve disorder caused by chronic hyperglycemia (high blood sugar). Excess glucose damages nerves directly and also harms the small blood vessels that supply oxygen and nutrients to the nerves.

It can affect:

• Peripheral nerves (hands and feet)

• Autonomic nerves (heart, digestion, bladder)

• Proximal nerves (hips, thighs)

• Focal nerves (specific nerves)

---

Types of Diabetic Neuropathy

1. Peripheral Neuropathy (Most Common)

This type mainly affects the feet and legs, followed by the hands and arms.

Symptoms include:

• Tingling or burning sensation

• Numbness

• Sharp or stabbing pain

• Increased sensitivity to touch

• Muscle weakness

Peripheral neuropathy is the leading cause of diabetic foot ulcers.

---

2. Autonomic Neuropathy

This affects nerves that control involuntary body functions.

Possible symptoms:

• Abnormal heart rate or blood pressure

• Digestive problems (gastroparesis, diarrhea)

• Bladder dysfunction

• Sexual dysfunction

• Reduced sweating

---

3. Proximal Neuropathy

Also known as diabetic amyotrophy, it affects the hips, thighs, or buttocks.

Symptoms:

• Severe pain in hip or thigh

• Muscle weakness

• Difficulty standing or walking

---

4. Focal Neuropathy

This involves sudden damage to a specific nerve, often in the face, head, or torso.

Symptoms may include:

• Double vision

• Facial paralysis

• Sharp localized pain

---

Causes and Risk Factors

Key factors that increase the risk of diabetic neuropathy include:

• Poor blood sugar control

• Long duration of diabetes

• High blood pressure

• High cholesterol

• Smoking

• Obesity

• Vitamin B12 deficiency (especially with long-term metformin use)

---

Diagnosis of Diabetic Neuropathy

Diagnosis is based on:

• Medical history

• Physical and neurological examination

• Sensory testing (vibration, temperature, touch)

• Nerve conduction studies (if needed)

Early screening is essential, especially for patients with long-standing diabetes.

---

Management and Treatment

1. Blood Sugar Control

Strict glycemic control is the most effective way to prevent or slow neuropathy progression.

• Regular glucose monitoring

• HbA1c target as advised by healthcare professionals

---

2. Medications for Neuropathic Pain

Commonly used medicines include:

• Pregabalin

• Gabapentin

• Duloxetine

• Amitriptyline (low dose)

Painkillers like NSAIDs are usually ineffective for nerve pain.

---

3. Vitamin Supplementation

• Vitamin B12

• Vitamin B complex

• Alpha-lipoic acid

These may support nerve health, especially in deficiency states.

---

4. Foot Care (Very Important)

• Daily foot inspection

• Proper nail trimming

• Wearing comfortable footwear

• Avoid walking barefoot

• Regular podiatric checkups

---

Prevention Strategies

Preventing diabetic neuropathy is possible with lifestyle changes:

• Maintain healthy blood glucose levels

• Follow a balanced diabetic diet

• Exercise regularly

• Quit smoking

• Control blood pressure and lipids

• Routine medical follow-ups

---

When to See a Doctor

Seek medical advice if you experience:

• Persistent numbness or tingling

• Burning or sharp pain in feet

• Foot wounds that heal slowly

• Loss of sensation

Early intervention can prevent permanent nerve damage.

---

Diabetic neuropathy is a serious but preventable complication of diabetes. With proper blood sugar control, healthy lifestyle choices, and timely treatment, patients can significantly reduce the risk of nerve damage and maintain a good quality of life.

Awareness is the first step. Managing diabetes effectively today can protect your nerves tomorrow

• 
  

Understanding Upadacitinib

Understanding Upadacitinib: A Breakthrough in Managing Inflammatory Conditions

In the ever-evolving landscape of pharmaceutical advancements, upadacitinib stands out as a potent tool for combating chronic inflammatory diseases. Marketed under the brand name Rinvoq by AbbVie, this oral medication has gained significant attention for its efficacy in treating a range of autoimmune and inflammatory disorders. As a selective Janus kinase (JAK) inhibitor, primarily targeting JAK1, 

upadacitinib helps modulate the immune response, reducing inflammation at its source. This article explores what Upadacitinib is, its uses, potential side effects, and its availability across key regions like the USA, Australia, and New Zealand, providing valuable insights for patients, caregivers, and healthcare enthusiasts worldwide.

Understanding Upadacitinib: 

What is Upadacitinib and How Does It Work?

Upadacitinib is a second-generation JAK inhibitor designed to interfere with the signaling pathways that drive inflammation in the body.e8cd1d JAK enzymes play a crucial role in cytokine signaling, which can go haywire in autoimmune conditions, leading to excessive inflammation and tissue damage. By selectively inhibiting JAK1, upadacitinib helps dampen this overactive response without broadly suppressing the immune system, potentially offering a more targeted approach compared to traditional therapies.

Approved as an extended-release tablet taken once daily, it's convenient for long-term management. This makes it particularly appealing for patients seeking alternatives to injectable biologics or those who haven't responded well to other treatments.

Approved Uses: From Arthritis to Skin Conditions

Upadacitinib has been authorized for multiple indications, reflecting its versatility in addressing inflammatory pathways. In the USA, it's approved by the FDA for:

Moderate to severe rheumatoid arthritis (RA) in adults who have had an inadequate response to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).3e337a

Active psoriatic arthritis (PsA).

Ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis.

Moderate to severe atopic dermatitis (eczema) in patients aged 12 and older.a26927

Moderately to severely active ulcerative colitis (UC) and Crohn's disease, with a recent label update in October 2025 allowing its use as a first-line advanced therapy for inflammatory bowel disease (IBD).ddb5f0

In Australia, the Therapeutic Goods Administration (TGA) has approved upadacitinib for similar conditions, including RA, PsA, AS, atopic dermatitis, UC, and Crohn's disease, often for patients who've tried other therapies without success.12e05d This aligns with global efforts to provide accessible options for chronic disease management.

New Zealand follows suit, with approvals through Medsafe for rheumatoid arthritis, Crohn's disease, ulcerative colitis, and atopic dermatitis.639e7f It's also recognized in broader international contexts, as noted in various health technology assessments.9108e2 Worldwide, upadacitinib is increasingly seen as a go-to option for those with refractory conditions, emphasizing its role in personalized medicine.

Dosage and Administration Guidelines

Typically administered as a once-daily oral tablet, dosages vary by condition. For rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, the standard dose is 15 mg daily. For ulcerative colitis and Crohn's disease, it may start at 45 mg for induction, followed by 15 mg or 30 mg for maintenance, depending on response and severity.70cbf3 Atopic dermatitis dosing is often 15 mg or 30 mg based on age and disease extent.

It's essential to take upadacitinib with or without food, but patients should follow their healthcare provider's instructions closely. Regular monitoring, including blood tests for liver function and blood counts, is recommended to ensure safety.

Potential Side Effects and Important Warnings

Like all powerful medications, upadacitinib comes with risks that must be weighed against its benefits. Common side effects include upper respiratory infections, nausea, headaches, and elevated cholesterol levels.8ab031 More serious concerns, highlighted in boxed warnings, involve increased risks of serious infections (such as tuberculosis or herpes zoster), malignancies (including lymphoma), major adverse cardiovascular events (like heart attacks), blood clots, and even mortality in certain populations, particularly those over 50 with cardiovascular risk factors.a49d18

Patients with a history of infections, cancer, or heart issues should discuss these risks thoroughly with their doctor. Vaccination updates, especially for shingles, are advised before starting treatment. Pregnant or breastfeeding individuals should avoid it due to potential fetal harm.

Global Availability and Considerations

Since its initial FDA approval in August 2019 for rheumatoid arthritis,dd65af upadacitinib has expanded its footprint globally. In the USA, it's widely available through prescriptions, often covered by insurance for approved indications. Australia and New Zealand offer it via public health systems like the Pharmaceutical Benefits Scheme (PBS) in Australia and Pharmac in New Zealand, making it accessible for eligible patients.c70a8c

For a worldwide audience, it's worth noting that availability and reimbursement can vary by country. Always consult local healthcare providers or regulatory bodies for the most current information. As of 2026, ongoing research continues to explore its potential in additional conditions, promising further innovations in inflammatory disease treatment.

Final Thoughtsk

Upadacitinib represents a significant step forward in the management of debilitating inflammatory conditions, offering hope toc millions struggling with daily symptoms. By providing targeted relief, it empowers patients to reclaim their quality of life. However, its use requires careful consideration of risks and benefits, underscoring the importance of shared decision-making with healthcare professionals. If you're considering upadacitinib or have experiences to share, we'd love to hear from you in the comments below. Stay informed and healthy!

Disclaimer: 

This article is for informational purposes only and not a substitute for professional medical advice. Consult your doctor for personalized guidance.

Top Global Health Challenges in 2026

Top Global Health Challenges

The global health landscape in 2026 remains under immense strain, shaped by funding crises, climate emergencies, infectious threats, and systemic weaknesses. 

As Naeem Mustafa, a pharmacist in Lahore, Punjab, running PharmaServePK, I observe these issues directly impacting our local pharmacies through antibiotic resistance, seasonal disease surges, and uncertainties in essential medicine supplies.

Drawing from key sources like Project HOPE's "6 Health Issues We're Watching in 2026," WHO priorities, World Economic Forum insights, and recent analyses, here are the top global health challenges defining this year. These interconnected threats call for urgent action, especially in vulnerable regions like Pakistan.

Top Global Health Challenges in 2026

1. Severe Funding Cuts and Retreat from Global Health Leadership

Development assistance for health has plummeted, with projections showing 30-40% reductions below 2023 levels due to donor fatigue, institutional changes (including major shifts at WHO), and geopolitical realignments. This jeopardizes vital programs for vaccines, HIV/TB/malaria control, maternal health, and outbreak responses.

In Pakistan, this translates to risks of shortages in antiretrovirals, childhood vaccines, and essential generics supported by international funds. As community pharmacists, we must strengthen local advocacy, promote rational prescribing, and build resilient supply chains to safeguard patient access.

2. Climate Change as a Major Driver of Health Crises

Climate impacts dominate 2026's agenda, with heatwaves causing widespread heat-related illnesses, extreme weather fueling malnutrition and displacement, and shifting vectors expanding diseases like malaria and dengue. Pakistan faces acute vulnerabilities recurring floods, air pollution-linked respiratory issues, and prolonged dengue seasons that overload pharmacies with demand for supportive treatments.

Pharmacists can contribute by stocking hydration aids, advising on preventive measures, and ensuring reliable supplies of antimalarials and vector-control medications.

3.Infectious Disease Outbreaks, Vaccination Gaps, and Escalating Antimicrobial Resistance (AMR)

Vaccination coverage continues to decline due to misinformation, conflicts, and funding shortfalls, heightening risks of measles, polio, and other preventable outbreaks. The threat of a novel "Disease X" persists, alongside gaps in pandemic preparedness.

AMR stands out as the "silent pandemic," with resistant infections already claiming millions of lives annually and projected to outpace cancer deaths by mid-century. In Pakistan, self-medication and agricultural overuse accelerate this crisis, making everyday antibiotics less effective in our daily dispensing.

We pharmacists hold a frontline role in antimicrobial stewardship—educating patients, enforcing prescription-only dispensing where possible, and promoting alternatives to preserve treatment efficacy.

These core challenges interconnect with others, including rising mental health burdens from economic stress and displacement, the growing load of non-communicable diseases (diabetes, hypertension, cardiovascular conditions) in our urbanizing populations, workforce shortages and burnout straining health systems, and fragmentation from ongoing conflicts.

Emerging factors like AI integration in healthcare offer promise for better diagnostics and access but also raise concerns around equity, data privacy, and misinformation.

As we move through 2026, this is a critical time to build resilience. In Pakistan, community-level efforts—rational drug use education, vaccination promotion, NCD counseling, and policy advocacy for stronger primary care are essential.

Let's prioritize equity, innovation, and collaboration to protect health for future generations.

By Naeem Mustafa

Pharmacist | PharmaServePK

Depression and Anxiety

Key Global Statistics (Based on Latest Available Data, Primarily 2021 with Updates Through 2023–2025)

According to the World Health Organization (WHO) and the Global Burden of Disease (GBD) studies from the Institute for Health Metrics and Evaluation (IHME):

Depression (depressive disorders): Approximately 332 million people worldwide were affected in 2021, representing about 5.7% of adults globally (4.6% in men and 6.9% in women). Women are around 1.5 times more likely to experience depression than men. Over 10% of pregnant women and new mothers experience it.

Anxiety disorders: Around 359 million people were affected in 2021, making it the most common mental disorder globally, with an estimated 4.4% of the population impacted.

Together, depression and anxiety are the leading contributors to the burden of mental disorders, accounting for a large share (around 63%) of all mental health cases in recent estimates.

Broader mental health conditions affect over 1 billion people worldwide (as per WHO updates in 2025), with anxiety and depression being the most prevalent types across all ages, genders, and income levels.

In 2023, IHME estimates indicate that about 15% of the world's population experienced mental disorders, with anxiety and depressive disorders ranking among the most burdensome.

The COVID-19 pandemic caused a sharp rise: In its first year (2020–2021), global prevalence of both anxiety and depression increased by about 25% compared to pre-pandemic levels, with lasting effects seen in elevated disability-adjusted life years (DALYs) through 2021 and beyond.

Trends and Burden

Between 2010–2021 and into recent years, age-standardized DALYs (a measure of healthy years lost) rose by around 16–17% for both depressive and anxiety disorders.

These conditions cost the global economy an estimated US$1 trillion per year in lost productivity.

Treatment gaps remain huge: Only about 1 in 4 people with anxiety disorders receive any treatment, due to stigma, lack of services, and underinvestment (especially in low- and middle-income countries).

Projections suggest continued increases due to population growth and other factors, potentially reaching over 466 million cases of depression and 515 million of anxiety by 2040 if trends persist.

Mental health conditions like these are universal—they occur everywhere, though prevalence and access to care vary by region, socioeconomic factors, and gender (women often report higher rates). If you're dealing with symptoms personally or know someone who is, reaching out to a healthcare professional, helpline, or trusted support can make a real difference—effective treatments like therapy, medication, or lifestyle support exist for most people.

For the most up-to-date interactive data, check sources like the WHO fact sheets or IHME's GBD tools.

The Global Importance of Vaccines

The Global Importance of Vaccines: A Worldwide Perspective

Vaccines train the immune system to defend against harmful pathogens before infection occurs, offering safe, effective prevention far superior to treating severe illness. Their impact is profound and measurable on a planetary scale.

Saving Millions of Lives Annually

Immunization averts an estimated 3.5 to 5 million deaths each year from diseases like diphtheria, tetanus, pertussis (whooping cough), measles, influenza, and more (WHO data). Childhood vaccination alone prevents around 4 million deaths worldwide annually, with projections showing over 50 million additional lives saved between 2021 and 2030 through sustained efforts.

The Global Importance of Vaccines

Historic Lifesaving Impact

Over the past 50 years, global immunization programs have saved approximately 154 million lives, with 146 million (95%) being children under five. Vaccines have contributed to a dramatic drop in infant mortality—from 92 to 25 per 1,000 live births since 1974—with about 40% of this reduction directly attributable to vaccination.

Preventing Severe Disease and Long-Term Harm

Vaccine-preventable diseases cause immense suffering: measles can lead to encephalitis and death; polio causes permanent paralysis; hepatitis B and HPV trigger cancers; tetanus brings agonizing lockjaw. Vaccines eliminate these risks preemptively, also reducing complications like brain damage, infertility, deafness, and lifelong disability.

Achieving Herd Immunity and Protecting the Vulnerable

High coverage (typically 95%+ for diseases like measles) creates community protection, shielding infants too young for vaccination, immunocompromised individuals, and those with medical contraindications. This collective shield curbs outbreaks and supports global health security.

Current Global Coverage and Progress (Latest 2024 Data)

According to the July 2025 WHO/UNICEF estimates (WUENIC):

85% of infants received the third dose of DTP (diphtheria-tetanus-pertussis) vaccine.

84% received the first dose of measles-containing vaccine (MCV1).

89% got at least one DTP dose, protecting about 115 million infants.

Coverage has held steady or slightly improved from 2023, with 1 million more children fully protected against DTP.

However, challenges persist: 14.3 million "zero-dose" children received no vaccines at all, and over 20 million missed key doses, fueling outbreaks (e.g., measles cases surged in 60 countries in 2024).

Economic and Societal Returns

Vaccines deliver exceptional value: $1 invested in childhood immunization yields up to $20 in savings for low- and middle-income countries through reduced healthcare costs, fewer hospitalizations, and preserved productivity. They enhance education, workforce participation, and economic growth by keeping populations healthy.

Ongoing Global Efforts and Future Outlook

Initiatives like the Immunization Agenda 2030 aim to avert 50 million more deaths by decade's end, with progress in introducing vaccines against HPV, pneumococcal disease, rotavirus, and more. Polio eradication efforts continue (99% reduction in cases since 1988), while seasonal vaccines (e.g., flu, COVID-19, RSV) protect against evolving threats. Yet, conflicts, misinformation, and access gaps threaten gains—making sustained vaccination essential everywhere.

In essence, vaccines are a cornerstone of modern civilization: they eradicate threats like smallpox, nearly eliminate polio, control measles globally, and prevent pandemics from spiraling. They protect not just individuals but entire societies, economies, and future generations.

As a pharmacist at PharmaServePK in 

Rahim Yar Khan, Punjab, I see vaccines bridging local communities to this global success story. Stay current with routine immunizations, boosters, and recommendations—consult healthcare providers for tailored advice.

Vaccination remains the safest, most powerful tool for a healthier world—one dose protecting billions.

Naeem Mustafa

Pharmacist, 

PharmaServePK

Diabetes and Erectile Dysfunction

Diabetes and Erectile Dysfunction: Understanding the Link and Effective Management Strategies

Erectile dysfunction (ED) remains one of the most challenging yet under-discussed complications of diabetes in men. 

Defined as the persistent inability to achieve or maintain an erection firm enough for satisfactory sexual activity, ED significantly impacts self-esteem, intimate relationships, and overall quality of life. For men with diabetes, this issue is far more common and often appears earlier and more severely than in the general population.

As a pharmacist dedicated to patient education, I've witnessed how addressing this connection empowers individuals to seek timely help and improve both their diabetes control and sexual health.

How Prevalent Is Erectile Dysfunction Among Men with Diabetes?

Recent global data paints a concerning picture. An umbrella review of studies estimates the pooled global prevalence of ED in diabetic men at approximately 65.8% (95% CI: 58.3–73.3%), making it over 3.5 times higher than in men without diabetes. In type 2 diabetes  the more common form rates often exceed 66%, while in type 1 diabetes, prevalence hovers around 37–48% in various cohorts.

Key risk factors amplifying this include:

Age over 40 years

Diabetes duration exceeding 10 years

Poor glycemic control (elevated HbA1c)

Obesity (BMI >30 kg/m²)

Comorbid conditions like hypertension, dyslipidemia, peripheral vascular disease, and smoking

These figures highlight that ED is not a rare side effect but a frequent marker of broader vascular and neurological damage in diabetes.

The Underlying Mechanisms: Why Diabetes Disrupts Erectile Function

An erection depends on coordinated vascular, neurological, hormonal, and psychological processes. Chronic hyperglycemia in diabetes interferes with all of these:

Endothelial and Vascular Damage

High blood sugar promotes endothelial dysfunction by reducing nitric oxide (NO) bioavailability — essential for relaxing smooth muscles in the penile arteries and allowing blood inflow. Advanced glycation end-products (AGEs), along with pathways like polyol, hexosamine, and protein kinase C activation, accelerate atherosclerosis and impair penile blood flow.

Neuropathy

Peripheral and autonomic nerve damage disrupts the neural signals required for arousal and erection. This includes impaired cavernous nerve function, leading to reduced smooth muscle relaxation.

Structural Changes in Penile Tissue

Fibrosis of the corpus cavernosum (tunica albuginea thickening) and cavernous smooth muscle atrophy reduce elasticity and expandability.

Hormonal and Metabolic Factors

Low testosterone is common in diabetic men due to obesity and insulin resistance. Psychosocial elements like depression, anxiety, or relationship strain further compound the issue.

These interconnected pathways create a vicious cycle where poor diabetes management worsens ED, and ED signals the need for intensified cardiovascular risk reduction — since penile vessels often show early signs of systemic atherosclerosis.

Proven Approaches to Management and Treatment

ED in diabetes is highly manageable, with many men regaining satisfactory function through a stepwise, personalized approach.

Prioritize Glycemic and Lifestyle Optimization

Achieving better blood sugar control (HbA1c ideally <7% for most) slows progression and may partially reverse early damage. Core lifestyle pillars include:

Balanced, low-glycemic diet

Regular aerobic and resistance exercise (≥150 minutes/week)

Sustainable weight loss

Smoking cessation and moderate alcohol intake

First-Line Pharmacotherapy: 

PDE5 Inhibitors

Oral phosphodiesterase-5 inhibitors (PDE5i) sildenafil, tadalafil, vardenafil, or avanafil — remain the cornerstone. They boost NO effects for improved blood flow. While response rates may be slightly lower in diabetic men due to advanced damage, daily low-dose tadalafil often provides consistent benefits. Always obtain a prescription, as interactions (e.g., with nitrates) can be dangerous.

Managing Comorbidities and Hormonal Issues

Control hypertension, lipids, and screen for hypogonadism — testosterone replacement can enhance outcomes if levels are low. Psychological support or counseling addresses emotional barriers.

Second- and Third-Line Options

Intracavernosal injections or intraurethral alprostadil

Vacuum erection devices

Penile prostheses for refractory cases

Emerging and Investigational Therapies

Promising developments include low-intensity extracorporeal shockwave therapy (Li-ESWT) to promote neovascularization, photobiomodulation (light therapy) targeting neuroinflammation, and regenerative approaches like stem cell-derived extracellular vesicles or platelet-rich plasma. These show potential in diabetic models but require more long-term evidence before widespread recommendation.

The 2025 American Diabetes Association Standards of Care explicitly recommend screening men with diabetes or prediabetes for ED during routine visits, emphasizing early intervention.

Diabetes and Erectile Dysfunction

Moving Forward: Breaking the Silence

Erectile dysfunction in diabetes is more than a sexual issue  it's often an early indicator of cardiovascular risk. Open dialogue with healthcare providers (endocrinologists, urologists, or primary care physicians) reduces stigma and unlocks effective solutions.

Men with diabetes deserve comprehensive care that includes sexual health. With proactive management, many can restore confidence and intimacy.

Written by Naeem Mustafa, Pharmacist

PharmaServePK  Empowering Health Through Knowledge and Care

(Disclaimer: This article is for educational purposes only. Consult a qualified healthcare professional for personalized diagnosis, treatment, or advice regarding diabetes or erectile dysfunction.)

Low-Dose GLP-1s

Low-Dose GLP-1s: Could They Be the First True Longevity Drugs? 2026 Science Update & Pharmacist Insights

By Naeem Mustafa, Pharmacist

Empowering Health Globally

In the whirlwind of 2025-2026, GLP-1 receptor agonists (GLP-1RAs) like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have exploded beyond diabetes and obesity. Now, at major aging conferences, experts from Novo Nordisk and Eli Lilly are boldly calling them potential "first longevity drugs" – not just for weight loss, but for extending healthspan (years of healthy, vibrant life).

The excitement? Emerging evidence shows these drugs counteract aging at a molecular level independent of significant weight loss. As a pharmacist tracking this daily, I'm seeing patients ask: "Can low doses help me age better?" Let's dive into the latest science, benefits, risks, and practical advice.

Low-Dose GLP-1s: Could They Be the First True Longevity 

Breakthrough Science: Body-Wide Anti-Aging in Mice (Independent of Weight Loss)

A landmark November 2025 study in Cell Metabolism treated aging male mice with exenatide (a GLP-1RA) at low doses for 30 weeks. Results were stunning:

Improved grip strength, coordination, and physical function (reversing age-related decline).

Broad rejuvenation across organs: brain, heart, liver, kidneys, and more.

Reversed molecular aging markers at transcriptomic (gene expression), epigenetic, and metabolomic levels.

Effects mirrored rapamycin (a proven longevity compound) and depended heavily on hypothalamic GLP-1 receptor signaling – without major appetite suppression or body weight changes.

This suggests GLP-1RAs target core aging hallmarks: chronic inflammation ("inflammaging"), mitochondrial dysfunction, and impaired nutrient sensing. Human data supports this – observational studies in diabetes/obesity patients show reduced all-cause mortality (up to 6-10%), lower cardiovascular/kidney risks, and potential neuroprotection (e.g., against cognitive decline).

At the 2025 Aging Research and Drug Discovery meeting in Copenhagen, Novo and Lilly reps highlighted these multi-organ benefits, sparking buzz that GLP-1s could prevent age-related diseases proactively.

Low-Dose / Microdosing: The Longevity Hack Trend in 2026?

Biohackers and longevity enthusiasts are experimenting with low-dose GLP-1s (e.g., 0.05–0.25 mg semaglutide weekly, far below standard obesity doses). Goals: subtle metabolic reset, inflammation control, and organ protection – without full weight loss or strong side effects.

Potential Benefits (backed by emerging data):

Reduced chronic inflammation and oxidative stress.

Better mitochondrial function and vascular health.

Cardio-renal protection (proven in high-risk groups; extending to broader use?).

Neuroprotection (early trials for Alzheimer's risk reduction).

Overall healthspan boost: more energy, less frailty.

In wellness communities, low doses are hailed for "metabolic optimization" in non-obese individuals.

But Hold On – Risks and Realities

Evidence is exciting but mostly preclinical (mice). Human longevity trials are ongoing – no definitive proof yet for low-dose in healthy people.

Key Risks

GI issues (nausea, vomiting) – even low doses can hit hard initially.

Potential muscle loss (mitigate with protein/exercise).

Rare concerns: thyroid issues, gallbladder problems, or mood changes (some studies note anxiety/depression risks).

Weight regain if stopped.

Off-label for longevity – not FDA-approved; compounded versions carry quality risks.

As a pharmacist, I emphasize: These are prescription meds. Low-dose use needs doctor supervision, regular monitoring (blood work, mental health), and lifestyle support.

Pharmacist Practical Tips for 2026

Titrate slowly – Start low to build tolerance and minimize GI upset.

Combine with habits – High-protein diet, resistance training, and wearables (e.g., Oura/Apple Watch) to track recovery and preserve muscle.

Monitor closely – Thyroid/kidney function, nutrients, and mood.

Who benefits most? Proven for obesity/diabetes; emerging for others – consult your healthcare provider.

Stay informed – 2026 brings oral GLP-1 expansions (Wegovy pill launched!), price competition, and more data.

GLP-1s are transforming health – from treating diseases to potentially preventing them. But longevity claims need more human evidence. They shine brightest where benefits are proven: metabolic health.

What’s your take? Thinking about GLP-1s for healthy aging? Drop comments below! Follow my GLP-1 Longevity Series for more updates.

References (key 2025 sources):

Huang et al. (2025). Body-wide multi-omic counteraction of aging with GLP-1R agonism. Cell Metabolism.

Nature Biotechnology (2025). Are GLP-1s the first longevity drugs?

Various reviews on healthspan benefits (PMC, Lancet, etc.).

Real-world mortality and regain data (2025 studies).

Acne and Treatment Options

Acne and Treatment Options:A Comprehensive Guide (2026 Update)

Acne vulgaris is one of the most common skin conditions worldwide, affecting millions of people across all ages, though it primarily strikes during adolescence and young adulthood. It can cause physical discomfort, permanent scarring, and significant emotional distress, including lowered self-esteem and social anxiety. The good news? Effective treatments exist, ranging from simple over-the-counter (OTC) solutions to advanced prescription therapies. As we move through 2026, guidelines from bodies like the American Academy of Dermatology (AAD) continue to emphasize evidence-based approaches that target the four main causes of acne: excess oil production, clogged pores, bacteria (Cutibacterium acnes), and inflammation.

Whether you're dealing with occasional breakouts or persistent moderate-to-severe acne, understanding your options as a pharmacist or patient can make a big difference. Here's a clear, up-to-date overview of acne and its proven treatments.

What Causes Acne?

Acne develops when hair follicles (pores) become blocked with oil (sebum), dead skin cells, and bacteria. Factors like hormones (especially during puberty, menstrual cycles, or stress), genetics, diet, and certain skincare products play a role. It often appears as:

Non-inflammatory 

Blackheads (open comedones) and whiteheads (closed comedones).

Inflammatory 

Papules, pustules, nodules, or cysts (more severe and likely to scar).

Early intervention is key to preventing scars and long-term damage.

Treatment Options: From Mild to Severe

Treatments are tailored by severity (mild, moderate, severe) and type. Start simple and escalate as needed. Always patch-test new products and use non-comedogenic (non-pore-clogging) moisturizers and sunscreen, as many acne treatments increase sun sensitivity.

1. 

Over-the-Counter (OTC) Treatments – Great Starting Point for Mild Acne

These target bacteria, unclog pores, and reduce inflammation without a prescription.

Benzoyl Peroxide (2.5–10%): Kills bacteria, mildly exfoliates, and prevents resistance. Available in washes, gels, creams (e.g., common brands in Pakistan like Acnes or generics). Start low to avoid dryness/irritation.

Salicylic Acid (0.5–2%): Beta-hydroxy acid that penetrates pores to exfoliate and clear blackheads/whiteheads. Found in cleansers, spot treatments.

Adapalene (0.1% gel, e.g., Differin): A gentle retinoid now OTC in many places — unclogs pores, reduces inflammation. Excellent for comedonal acne.

Azelaic Acid (10–20%): Antibacterial, anti-inflammatory, and helps fade post-acne marks. Gentle for sensitive skin.

Tip: Combine benzoyl peroxide (morning) with adapalene (night) for better results, but introduce slowly to minimize purging (temporary worsening as pores clear).

2. Prescription Topical Treatments – For Moderate Acne or When OTC Isn't Enough

These are stronger and often combined for multi-action effects.

Topical Retinoids (e.g., tretinoin/Skin A, tazarotene/Tazorac, trifarotene): Normalize skin cell turnover, prevent clogging. Start low strength; irritation common initially.

Topical Antibiotics (e.g., clindamycin in Benclin Gel, erythromycin): Reduce bacteria and inflammation — always pair with benzoyl peroxide to prevent resistance.

Combination Products (e.g., adapalene + benzoyl peroxide/Epiduo equivalents, clindamycin + benzoyl peroxide): Convenient and highly effective.

Newer Options (e.g., clascoterone/Winlevi): Topical anti-androgen that blocks hormones causing oil production — great for hormonal acne.

Azelaic Acid (higher strength, e.g., Skinoren Cream): Prescription versions for stubborn cases.

In Pakistan, popular prescriptions include Skinoren (azelaic acid), Adapco (adapalene), Benclin, and Acdermin gels — widely available at pharmacies.

3. Oral (Systemic) Treatments – For Moderate-to-Severe or Widespread Acne

When topicals fail or acne is scarring/inflammatory.

Oral Antibiotics (e.g., doxycycline — strongly recommended; minocycline, sarecycline): Short-term (3–4 months) to reduce bacteria/inflammation. Combine with topicals; limit use to avoid resistance.

Hormonal Therapies (for women): Combined oral contraceptives (e.g., Diane-35) or spironolactone to balance hormones.

Isotretinoin (e.g., Oratane, Arynoin capsules): Gold standard for severe, nodular, or treatment-resistant acne. Highly effective (often clears skin long-term), but requires monitoring for side effects (dryness, mood changes, birth defects — strict precautions needed).

4. Procedures and Advanced Therapies

For stubborn cases or scarring:

Intralesional corticosteroid injections → Quick reduction of large, painful cysts.

Chemical peels, laser/light therapy → Reduce inflammation, improve texture.

Extraction → Professional removal of comedones (never DIY to avoid scarring).

Lifestyle and Skincare Tips for Better Results

Wash gently twice daily with a mild cleanser (avoid harsh scrubbing).

Moisturize — even oily skin needs hydration to prevent overproduction of oil.

Use non-comedogenic makeup/sunscreen.

Avoid picking/squeezing — it worsens inflammation and scars.

Diet: Some evidence links high-glycemic foods/dairy to worsening acne, but results vary.

Manage stress — it can trigger flares.

When to See a Dermatologist (or Consult Your Pharmacist)

If OTC fails after 6–8 weeks, acne is scarring, painful/cystic, or affecting mental health — seek professional help early. In Pakistan, affordable consultations and generics make treatment accessible.

Acne and Treatment Options

Acne is treatable patience (results take 4–12 weeks) and consistency pay off. With the right approach, clearer skin is achievable. For personalized advice, 

visit a Dermatologist or your trusted pharmacist at PharmaServePK.

Vitamin D3

Vitamin D3: The Essential Sunshine Vitamin A Global Health Perspective

Vitamin D3, scientifically known as cholecalciferol, is a vital fat-soluble nutrient that functions as a pro hormone in the body. It supports bone health, immune function, muscle strength, and emerging evidence points to benefits in heart health, cancer risk reduction, and even slowing biological aging.

Here are detailed illustrations of the molecular structure of Vitamin D3 (cholecalciferol):

Vitamin D3

How Vitamin D3 is Naturally Produced

The body's most efficient source of Vitamin D3 comes from sunlight exposure. UVB rays convert 7-dehydrocholesterol in the skin into previtamin D3, which isomerizes into active cholecalciferol.

These diagrams illustrate the Vitamin D3 synthesis pathway in the skin from sun exposure:

Despite varying sunlight availability worldwide, modern lifestyles (indoor work, clothing, sunscreen, pollution) often limit this natural production.

Dietary Sources of Vitamin D3

Few foods naturally provide high amounts of Vitamin D3, but top sources include:

Fatty fish (salmon, mackerel, sardines)

Cod liver oil

Egg yolks

Fortified foods (milk, cereals in some countries)

Enjoy these vibrant examples of Vitamin D-rich foods:

Flat Lay of Vitamin D-rich Foods Including Salmon, Eggs, and ...

The Role of Supplements Worldwide

For many, especially in regions with limited sun or dietary sources, Vitamin D3 supplements (capsules or softgels) are a reliable way to maintain optimal levels.

Here are common Vitamin D3 supplement options widely available globally:

Vitamin D3 Super-Potency 2000 iu 50 mcg 200 Softgels D-3 Bone ...

Key Health Benefits of Vitamin D3

Vitamin D3 is crucial for:

Bone and muscle health — Enhances calcium absorption to prevent rickets, osteomalacia, and osteoporosis.

Immune support — Modulates immune responses and may reduce infection risks.

Emerging benefits — Recent 2025 studies show Vitamin D3 supplementation preserves telomere length (slowing biological aging by up to ~3 years), halves the risk of recurrent heart attacks in targeted dosing, reduces inflammation in conditions like colorectal cancer, and supports cardiometabolic health.

The Global Challenge: Vitamin D Deficiency

Vitamin D deficiency remains a widespread issue. A major 2023 pooled analysis of 7.9 million people (updated trends into recent years) estimates:

~15.7% have severe deficiency (<30 nmol/L)

~47.9% have insufficiency (<50 nmol/L)

Prevalence is higher in high-latitude regions, winter months, females, and lower-middle-income countries, though it affects populations worldwide. Recent data (up to 2025) confirm persistent high rates, with over 1 billion people potentially impacted globally.

These visuals highlight common signs and symptoms of Vitamin D deficiency (fatigue, bone pain, muscle weakness):

14 silent Vitamin D deficiency signs: 

14 silent Vitamin D ...

Practical Tips for Optimal Vitamin D3 Levels

Get 10-30 minutes of midday sun exposure (arms, face, legs) several times a week when possible.

Include Vitamin D-rich foods in your diet.

Consider supplements (typically 1000-4000 IU daily for adults, but get tested first).

Monitor via a 25(OH)D blood test and consult a healthcare professional.

Safe, moderate sun exposure remains enjoyable and effective:

Here’s an inspiring example of getting natural sunlight safely:

Can You Still Tan with Sunscreen? Discover Truths

In our modern world, Vitamin D3 deficiency is largely preventable. Awareness, balanced sun exposure, diet, and guided supplementation can significantly enhance global health outcomes.

Embrace the sunshine vitamin for stronger bones, better immunity, and a healthier future!

Authored by Naeem Mustafa

PharmaServePK – Your Trusted Health Companion

New AI Technology and the Health System

 

New AI Technology and the Health System: Transforming Healthcare for the Future

 

Author: Naeem Mustafa, Pharmacist

Platform: PharmaServePK

Introduction

Artificial Intelligence (AI) is rapidly reshaping the global healthcare landscape. From early disease detection to personalized treatment plans, new AI technologies are transforming how health systems operate, improving efficiency, accuracy, and patient outcomes. As healthcare demands continue to rise worldwide, especially in developing countries like Pakistan, AI offers innovative solutions to bridge gaps in care, reduce costs, and enhance decision-making.

This article explores the role of new AI technology in the health system, its key applications, benefits, challenges, and future potential.

Understanding Artificial Intelligence in Healthcare

Artificial Intelligence refers to computer systems designed to perform tasks that normally require human intelligence. In healthcare, AI uses technologies such as:

New AI Technology and the Health System

Machine Learning (ML)

Deep Learning

Natural Language Processing (NLP)

Computer Vision

These technologies analyze large volumes of medical data to identify patterns, predict outcomes, and support clinical decisions with high accuracy.

Key Applications of AI in the Health System

1. AI in Disease Diagnosis and Early Detection

One of the most impactful uses of AI is in disease diagnosis. AI-powered tools can analyze medical images such as X-rays, CT scans, and MRIs faster and sometimes more accurately than human experts.

Early detection of cancer

Identification of heart diseases

Detection of diabetic retinopathy

AI-assisted radiology and pathology

Early diagnosis leads to timely treatment, reduced complications, and improved survival rates.

2. AI in Personalized Medicine

AI enables personalized treatment by analyzing a patient’s genetics, lifestyle, and medical history.

Customized drug selection

Personalized dosage recommendations

Reduced adverse drug reactions

Improved treatment outcomes

This approach is especially beneficial in chronic diseases like diabetes, hypertension, and cancer.

3. AI in Drug Discovery and Development

Traditional drug development is costly and time-consuming. AI significantly accelerates this process by:

Identifying potential drug molecules

Predicting drug effectiveness and safety

Reducing research time and cost

AI played a crucial role during the COVID-19 pandemic by speeding up vaccine and treatment research.

4. AI in Hospital Management and Operations

AI improves hospital efficiency by optimizing administrative and operational tasks such as:

Patient scheduling

Bed management

Predicting patient admission rates

Reducing waiting times

Smart AI systems help healthcare providers focus more on patient care rather than paperwork.

5. AI-Powered Virtual Assistants and Chatbots

AI chatbots and virtual health assistants provide 24/7 support to patients by:

Answering health-related queries

Providing medication reminders

Offering mental health support

Guiding patients to appropriate care

These tools are particularly useful in remote and underserved areas.

6. AI in Pharmacy Practice

AI is transforming pharmacy services by:

Improving prescription accuracy

Detecting drug interactions

Managing inventory efficiently

Supporting clinical decision-making

For pharmacists, AI acts as a powerful support tool to enhance patient safety and pharmaceutical care.

Benefits of AI in the Health System

The integration of AI into healthcare offers multiple advantages:

Improved accuracy and efficiency

Reduced healthcare costs

Enhanced patient safety

Faster diagnosis and treatment

Better resource utilization

Support for healthcare professionals

AI does not replace healthcare workers but strengthens their ability to deliver quality care.

Challenges and Ethical Concerns

Despite its benefits, AI in healthcare faces several challenges:

Data privacy and security risks

Lack of standardized regulations

Bias in AI algorithms

Limited infrastructure in low-income countries

Need for skilled professionals

Ethical use of AI, transparent algorithms, and strong regulatory frameworks are essential to build trust and ensure patient safety.

AI and the Future of Healthcare in Pakistan

In Pakistan, AI has immense potential to improve healthcare delivery by:

Supporting telemedicine services

Enhancing disease surveillance

Improving rural healthcare access

Assisting overburdened health systems

Government initiatives, investment in digital health, and collaboration between healthcare professionals and technology experts are key to successful AI adoption.

New AI technology is revolutionizing the health system by making healthcare smarter, faster, and more patient-centered. From diagnosis to treatment, hospital management to pharmacy practice, AI is shaping the future of medicine.

For healthcare professionals, including pharmacists, embracing AI is no longer optional—it is essential. With responsible implementation and ethical oversight, AI can significantly improve health outcomes and strengthen healthcare systems worldwide.

Written by:

Naeem Mustafa, Pharmacist

For PharmaServePK

Unlocking a Century of Vitality

Unlocking a Century of Vitality: Science-Backed Foods for a Long, Healthy Life

By Naeem Mustafa, Pharmacist

PharmaServePK - Trusted Global Health & Wellness Insights

As a pharmacist committed to evidence-based health advice, I regularly review the latest global research on nutrition and longevity. Studies from Blue Zones 

(regions like Okinawa, Sardinia, and Ikaria where people routinely live to 100+) 

Unlocking a Century of Vitality

The Mediterranean diet (ranked the healthiest in 2025 rankings), and large cohort analyses consistently highlight one key truth: a predominantly plant-based diet rich in whole, nutrient-dense foods is strongly linked to longer life expectancy, reduced chronic disease risk (heart disease, cancer, diabetes), and better health span.

Recent 2025-2026 evidence reinforces that shifting toward more legumes, whole grains, nuts, fruits/vegetables, and healthy fats like extra virgin olive oil — while limiting red/processed meats and ultra-processed foods — can add years to life. Modeling studies estimate gains of 8–13+ years when adopted early, with benefits seen worldwide.

Here are the top globally recognized, evidence-backed foods for promoting longevity:

1. Nuts – A Daily Handful for Heart and Overall Protection

Daily nut consumption (about 25–30g) is one of the most consistent predictors of reduced mortality in global studies. Almonds, walnuts, pistachios, and others provide healthy fats, fiber, vitamin E, and antioxidants that lower inflammation and support cardiovascular health.

Here are vibrant examples of mixed nuts as a perfect daily snack:

Pharmacist insight: Nuts help stabilize blood sugar and cholesterol — simple yet powerful for long-term wellness.

2. Berries – Antioxidant-Rich Brain and Heart Guardians

Berries (blueberries, strawberries, raspberries) top lists for their polyphenols and flavonoids, which combat oxidative stress, support cognitive health, and reduce inflammation. Regular intake links to slower aging and lower chronic disease risk.

Bright, fresh berries are an easy longevity boost:

Fresh Cut Mixed Berries Fruit Mix, 9 oz - Smith's Food and Drug

Tip: Enjoy fresh, frozen, or in yogurt/oatmeal available worldwide.

3. Legumes & Beans – The Universal Longevity Cornerstone

Beans, lentils, chickpeas, and soybeans appear in every Blue Zone and Mediterranean pattern. They deliver plant protein, fiber, and gut-supporting compounds. Studies show higher intake strongly predicts survival into old age.

4. Extra Virgin Olive Oil – The Mediterranean Staple for Cellular Health

EVOO, rich in oleic acid and polyphenols, is central to the Mediterranean diet's proven benefits for heart health and reduced mortality.

A classic Mediterranean-style plate combines many longevity foods:

Ultimate Mediterranean Diet Foods List

Your Simple Global Longevity Blueprint

Adopt this practical pattern:

Breakfast: 

Whole-grain oatmeal with berries + a handful of nuts

Here’s an inspiring example:

Healthy Oatmeal with Fruit and Nuts

Meals: 

Emphasize vegetables, legumes, whole grains, and olive oil; add fish occasionally if desired.

Rule: 90–95%+ plant-based; minimize processed foods, red/processed meats, and sugars.

Longevity comes from consistency, not perfection. Start small — add nuts and berries daily — and pair with activity, sleep, and social connections. 

Global research shows these habits work across cultures for vibrant, extended years.

Stay Healthy and strong,

Naeem Mustafa

Pharmacist

PharmaServePK.

Managing Diabetes Worldwide

Managing Diabetes Worldwide: Practical Tips & Latest Global Insights (2026 Edition)
By Naeem Mustafa, Pharmacist

pharmaservepk 

January 10, 2026

Diabetes is a global health emergency affecting hundreds of millions. According to the International Diabetes Federation (IDF) Diabetes Atlas 11th Edition (2025), an estimated 589 million adults (aged 20–79 years) were living with diabetes in 2024 — that's 1 in 9 adults worldwide, or about 11.1% of the global adult population. Projections show this number rising to 853 million by 2050, a 45% increase, driven by aging populations, urbanization, obesity, and lifestyle changes. Over 252 million people (43%) remain undiagnosed, highlighting the urgent need for awareness and early detection.

Managing Diabetes Worldwide

As a pharmacist, I've seen how consistent management empowers people everywhere to live healthier lives. Whether you have type 1 or type 2 diabetes (the most common), these practical, evidence-based tips — aligned with the American Diabetes Association (ADA) Standards of Care in Diabetes—2026 — can help you thrive.

1. Know Your Targets and Get Regular Monitoring

Understanding your numbers is the foundation of good control.

Aim for fasting blood glucose 80–130 mg/dL, post-meal <180 mg/dL, and HbA1c <7% (personalized by your doctor based on age, health, and risks).

Regular check-ups catch complications early (e.g., eyes, kidneys, heart).

The 2026 ADA Standards emphasize person-centered care, using empowering language and focusing on individual needs.

2. Build a Balanced, Diabetes-Friendly Plate

Healthy eating doesn't mean giving up flavor — focus on portion control and nutrient-dense foods.

Here are examples of balanced diabetic-friendly meals using the Plate Method (half non-starchy veggies, quarter lean protein, quarter whole grains):

These visuals show simple, satisfying plates with veggies, proteins like fish/chicken/beans, and whole grains — ideal for steady blood sugar.

Tips: Choose fiber-rich foods (vegetables, legumes, whole grains), limit added sugars/processed carbs, and include healthy fats (nuts, avocado, olive oil). Eat regular meals to avoid spikes.

3. Stay Active — Movement Makes a Difference

Aim for at least 150 minutes of moderate activity per week, like brisk walking.

Physical activity improves insulin sensitivity, aids weight management, and reduces risks.

See how everyday walking helps:

Start small — even short walks after meals lower post-meal sugars effectively.

4. Prioritize Foot Care to Prevent Complications

Diabetes can affect nerves and circulation, making foot issues common and serious.

Daily checks and proper care prevent ulcers and infections.

Here are helpful guides for diabetic foot inspection and care:

Key steps: Inspect feet daily, wear well-fitted shoes, keep skin moisturized (avoid between toes), and seek professional help for any cuts/redness.

5. Leverage Modern Technology for Smarter Management

The 2026 ADA Standards expand access to tools like Continuous Glucose Monitoring (CGM) and Automated Insulin Delivery (AID) systems.

CGM provides real-time readings, spotting trends without frequent finger pricks — recommended at diagnosis for insulin users and many others.

Examples of CGM in daily life:

Discuss with your healthcare team — these tools are game-changers for better control and fewer lows/highs.

Diabetes is manageable worldwide with knowledge, healthy habits, and support. Focus on prevention, regular monitoring, balanced nutrition, activity, foot care, and emerging technologies.

Have you found a favorite way to stay active or use tech for diabetes? Share your experiences in the comments — we're all in this together!

Stay empowered and healthy. Follow pharmaservepk for more global pharma insights and tips.

References:

IDF Diabetes Atlas 11th Edition (2025)

ADA Standards of Care in Diabetes—2026

Naeem Mustafa, Pharmacist

The Dawn of the Oral GLP-1 Era

The Dawn of the Oral GLP-1 Era: Novo Nordisk Launches Wegovy Pill and Sparks a Global Price War

In a landmark moment for obesity treatment, Novo Nordisk has ushered in the oral GLP-1 era with the U.S. launch of the Wegovy pill—the first once-daily oral formulation of semaglutide approved specifically for weight management. Available starting January 5, 2026, this needle-free option arrives at aggressively low prices, intensifying competition in the booming GLP-1 market and signaling a shift toward greater accessibility worldwide.

The Dawn of the Oral GLP-1 Era

The Wegovy pill, containing the same active ingredient as the blockbuster injectable Wegovy and diabetes drug Ozempic, received FDA approval on December 22, 2025. Clinical data from the pivotal OASIS 4 trial demonstrated impressive efficacy: patients on the highest 25 mg dose achieved an average weight loss of up to 16.6% when adhering to treatment, with around 14% loss overall. This performance mirrors the injectable version while offering the convenience of a daily tablet.

What truly sets this launch apart is the pricing strategy. Novo Nordisk has positioned the pill as an affordable entry point, with the starting 1.5 mg and 4 mg doses available for just $149 per month for self-paying patients—a fraction of the typical $1,000+ list prices for GLP-1 injections. Higher doses (9 mg and 25 mg) are priced at $299, with the 4 mg dose rising to $199 after April 15, 2026. Insured patients may pay as little as $25 monthly through savings programs. Distributed through major pharmacies like CVS and Costco, as well as telehealth platforms, the pill is designed to reach patients deterred by injections or high costs.

This bold move has ignited a price war in the GLP-1 space. Novo Nordisk's aggressive discounts aim to recapture market momentum after a challenging 2025, where rival Eli Lilly gained ground with Mounjaro and Zepbound injections. Analysts note that the low pricing could pressure competitors to respond, potentially accelerating affordability globally. While the Wegovy pill is currently U.S.-only, Novo has submitted for approvals elsewhere, hinting at broader international rollout.

The timing couldn't be better: with over 100 million Americans affected by obesity, the pill eliminates barriers like needle phobia and refrigeration needs. Patients must take it on an empty stomach, waiting 30 minutes before eating, but the trade-off for convenience and cost appears worthwhile for many.

Looking ahead, Eli Lilly's experimental oral GLP-1, orforglipron, looms as the next contender. Expected FDA decision by March 2026, it promises no food restrictions and strong efficacy in trials. If approved, it could challenge Novo's first-mover advantage, further driving innovation and price competition.

Novo Nordisk's Wegovy pill doesn't just expand treatment options—it redefines them. By prioritizing accessibility over premium pricing, the company is betting on volume to fuel growth in a market projected to explode. For millions seeking sustainable weight management, the oral era has arrived, promising a more inclusive future in the fight against obesity. As competition heats up, patients stand to benefit most from this transformative shift.